How eating pearl millet affects fat levels and body weight

Study the impact of pearl millet consumption on lipid profile and body weight - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077943

Enrollment

Registered

2024-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: Pearl millet-based diet along with standard of care: Pearl millet based diet (90-100gm per day) replacing one of the three meal (33% of total cereal intake) in any preparation like rot

Eligibility

Inclusion criteria

Inclusion criteria: Bmi more than or equal to 25kg/m2 Dyslipidemia-Any one of the following without indication of lipid lowering drug Triglyceride more than or equal to 150mg/dl HDL cholesterol less than 40 in men, less than 50 in women Total Cholesterol more than or equal to 200mg/dl LDL more than or equal to 100mg/dl Individuals not planning for nay pharmacotherapy and bariatric surgery for obesity in next 3 month

Exclusion criteria

Exclusion criteria: Type 2 Diabetes Mellitus (FBS more than or equal to 126mg/dL,PPBS more than or equal to 200mg/dL ,HbA1c more than or equal to 6.5%) On medication for Obesity/Dyslipidaemia Already on Millet based diet plan in past 3 months On medication which affect the lipid profile and body weight (statins,ART,antiepileptics/psychotics,OHA,beta blockers,VitA analogues.) Chronic heavy alcohol user(consuming 40-80g/day for men,20-40g/day for women) and patient with known psychiatric illnesses(eating disorder) Acute or chronic heart failure, CKD (Stage 3 or more), CLD (Child class B or C), Acute and chronic infections eg HIV, tuberculosis, chronic Hep C and Hep B Known active malignancies.

Design outcomes

Primary

Measure	Time frame
To study the impact of Pearl Millet consumption on body weight and lipid profile among Obese individuals with DyslipidemiaTimepoint: Shall be assessed at baseline and after 12 weeks	—

Secondary

Measure	Time frame
To assess the effect of pearl millet consumption on glycemic parameters, including fasting and postprandial blood glucose and HbA1c levels, as well as on insulin resistance (HOMA-IR and HOMA-B) in obese patientsTimepoint: Shall be assessed at baseline and after 12 weeks	—

Countries

India

Contacts

Public ContactDr Ranveer Singh Jadon

AIIMS New Delhi

rsjadonaiims@gmail.com9540951048

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026